Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare form of diffuse large B-cell lymphoma occurring most commonly in patients over the age of 50 (usually between 70-75 years of age), without overt immunodeficiency, and presenting with nodal and extranodal involvement (in sites such as the stomach, lung, skin and pancreas) and B symptoms (fever, night sweats, weight loss). The tumor is characterized by an aggressive course and a short survival rate.
Biomarker and diagnostic research for Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
33 publications have been identified in PubMed for Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly. Research spans Case Report / Case Series (48%), Review / Meta-Analysis (18%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly
Research summaries | 6 | 18% |
Laboratory research | 5 | 15% |
Disease patterns and progression | 4 | 12% |
Testing and diagnosis research | 2 | 6% |
Leeper K (2026). [PMID: 41718415](https://pubmed.ncbi.nlm.nih.gov/41718415/). *Hematology reports*. [Case Report / Case Series]
Nagase S (2026). [PMID: 41371409](https://pubmed.ncbi.nlm.nih.gov/41371409/). *Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc*. [Review / Meta-Analysis]
Qiaochu L (2026). [PMID: 41668558](https://pubmed.ncbi.nlm.nih.gov/41668558/). *Hematology (Amsterdam, Netherlands)*. [Case Report / Case Series]
Shiddapur GS (2026). [PMID: 41722064](https://pubmed.ncbi.nlm.nih.gov/41722064/). *Annals of African medicine*. [Case Report / Case Series]
García-Cadenas I (2026). [PMID: 41502050](https://pubmed.ncbi.nlm.nih.gov/41502050/). *European journal of haematology*. [Epidemiology / Natural History]
Huang HH (2026). [PMID: 41576253](https://pubmed.ncbi.nlm.nih.gov/41576253/). *Annals of plastic surgery*. [Case Report / Case Series]
Vets J (2026). [PMID: 41934612](https://pubmed.ncbi.nlm.nih.gov/41934612/). *Expert Rev Hematol*. [Review / Meta-Analysis]
Zheng W (2026). [PMID: 41775689](https://pubmed.ncbi.nlm.nih.gov/41775689/). *Cell Death Dis*. [Basic Science / Preclinical]
Popov VM (2026). [PMID: 42084518](https://pubmed.ncbi.nlm.nih.gov/42084518/). *Oncology (Williston Park)*. [Case Report / Case Series]
Wang X (2025). [PMID: 39912808](https://pubmed.ncbi.nlm.nih.gov/39912808/). *American journal of clinical pathology*. [Review / Meta-Analysis]
AI-curated news mentioning Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly
Updated Feb 20, 2026
A recent study highlights a case of Epstein-Barr virus-positive diffuse large B-cell lymphoma presenting as pyrexia of unknown origin, complicated by paraneoplastic neurological syndrome. This research adds to the understanding of the complex interactions between viral infections and lymphoproliferative disorders.